Department of Clinical Genetics, Odense University Hospital, Odense, Denmark; Otorhinolaryngology, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark.
Department of Clinical Genetics, Odense University Hospital, Odense, Denmark; Human Genetics, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark.
PLoS One. 2014 Mar 6;9(3):e90272. doi: 10.1371/journal.pone.0090272. eCollection 2014.
Hereditary Haemorrhagic Telangiectasia (HHT) is an autosomal dominantly inherited vascular disease characterized by the presence of mucocutaneous telangiectasia and arteriovenous malformations in visceral organs. HHT is predominantly caused by mutations in ENG and ACVRL1, which both belong to the TGF-β signalling pathway. The exact mechanism of how haploinsufficiency of ENG and ACVRL1 leads to HHT manifestations remains to be identified. As long non-coding RNAs (lncRNAs) are increasingly recognized as key regulators of gene expression and constitute a sizable fraction of the human transcriptome, we wanted to assess whether lncRNAs play a role in the molecular pathogenesis of HHT manifestations. By microarray technology, we profiled lncRNA transcripts from HHT nasal telangiectasial and non-telangiectasial tissue using a paired design. The microarray probes were annotated using the GENCODE v.16 dataset, identifying 4,810 probes mapping to 2,811 lncRNAs. Comparing HHT telangiectasial tissue with HHT non-telangiectasial tissue, we identified 42 lncRNAs that are differentially expressed (q<0.001). Using GREAT, a tool that assumes cis-regulation, we showed that differently expressed lncRNAs are enriched for genomic loci involved in key pathways concerning HHT. Our study identified lncRNAs that are aberrantly expressed in HHT telangiectasia and indicates that lncRNAs may contribute to regulate protein-coding loci in HHT. These results suggest that the lncRNA component of the transcriptome deserves more attention in HHT. A deeper understanding of lncRNAs and their role in telangiectasia formation possesses potential for discovering therapeutic targets in HHT.
遗传性出血性毛细血管扩张症(HHT)是一种常染色体显性遗传性血管疾病,其特征是存在粘膜皮肤毛细血管扩张和内脏器官动静脉畸形。HHT 主要由 ENG 和 ACVRL1 的突变引起,这两者都属于 TGF-β信号通路。ENG 和 ACVRL1 的单倍不足如何导致 HHT 表现的具体机制仍有待确定。由于长非编码 RNA(lncRNAs)被越来越多地认为是基因表达的关键调节剂,并构成人类转录组的相当大一部分,我们想评估 lncRNAs 是否在 HHT 表现的分子发病机制中发挥作用。通过微阵列技术,我们使用配对设计从 HHT 鼻毛细血管扩张和非毛细血管扩张组织中对 lncRNA 转录本进行了分析。微阵列探针使用 GENCODE v.16 数据集进行注释,确定了 4810 个探针映射到 2811 个 lncRNAs。比较 HHT 毛细血管扩张组织和 HHT 非毛细血管扩张组织,我们确定了 42 个差异表达的 lncRNA(q<0.001)。使用 GREAT,一个假设顺式调控的工具,我们表明差异表达的 lncRNAs 富含与 HHT 关键途径相关的基因组位点。我们的研究鉴定了在 HHT 毛细血管扩张中异常表达的 lncRNAs,并表明 lncRNAs 可能有助于调节 HHT 中的蛋白质编码基因座。这些结果表明,转录组中的 lncRNA 成分在 HHT 中值得更多关注。更深入地了解 lncRNAs 及其在毛细血管扩张形成中的作用,有可能在 HHT 中发现治疗靶点。